Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 2
1976 3
1978 4
1979 5
1980 1
1981 2
1982 5
1983 12
1984 16
1985 16
1986 17
1987 17
1988 16
1989 17
1990 17
1991 25
1992 18
1993 16
1994 14
1995 25
1996 15
1997 20
1998 15
1999 21
2000 15
2001 15
2002 15
2003 16
2004 19
2005 22
2006 24
2007 12
2008 6
2009 3
2010 4
2011 4
2012 4
2013 2
2014 2
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

472 results

Results by year

Filters applied: . Clear all
Page 1
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. Therasse P, et al. Among authors: van oosterom at. J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205. J Natl Cancer Inst. 2000. PMID: 10655437
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. Demetri GD, et al. Among authors: van oosterom at. Lancet. 2006 Oct 14;368(9544):1329-38. doi: 10.1016/S0140-6736(06)69446-4. Lancet. 2006. PMID: 17046465 Clinical Trial.
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.
Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L; EORTC Genito-Urinary Cancer Group. Sternberg CN, et al. Among authors: van oosterom at. Eur J Cancer. 2006 Jan;42(1):50-4. doi: 10.1016/j.ejca.2005.08.032. Epub 2005 Dec 5. Eur J Cancer. 2006. PMID: 16330205 Clinical Trial.
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Sternberg CN, et al. Among authors: van oosterom at. J Clin Oncol. 2001 May 15;19(10):2638-46. doi: 10.1200/JCO.2001.19.10.2638. J Clin Oncol. 2001. PMID: 11352955 Clinical Trial.
Soft tissue sarcoma in adults.
Dirix LY, Vermeulen P, De Wever I, Van Oosterom AT. Dirix LY, et al. Among authors: van oosterom at. Curr Opin Oncol. 1997 Jul;9(4):348-59. doi: 10.1097/00001622-199709040-00008. Curr Opin Oncol. 1997. PMID: 9251885 Review.
Nanotechnology in bio/clinical analysis.
Guetens G, Van Cauwenberghe K, De Boeck G, Maes R, Tjaden UR, van der Greef J, Highley M, van Oosterom AT, de Bruijn EA. Guetens G, et al. Among authors: van oosterom at. J Chromatogr B Biomed Sci Appl. 2000 Feb 28;739(1):139-50. doi: 10.1016/s0378-4347(99)00553-8. J Chromatogr B Biomed Sci Appl. 2000. PMID: 10744322 Review.
Vascular endothelial growth factor and angiogenesis.
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Hoeben A, et al. Among authors: van oosterom at. Pharmacol Rev. 2004 Dec;56(4):549-80. doi: 10.1124/pr.56.4.3. Pharmacol Rev. 2004. PMID: 15602010 Review.
Primary mediastinal leiomyosarcoma.
Van Schil PE, Colpaert CG, Van Look R, Van Oosterom AT, Van marck EA, Reher SW, Schoofs EL. Van Schil PE, et al. Among authors: van oosterom at. Thorac Cardiovasc Surg. 1993 Dec;41(6):377-8. doi: 10.1055/s-2007-1013895. Thorac Cardiovasc Surg. 1993. PMID: 8128470 Review.
Pharmacology of anticancer drugs in the elderly population.
Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT. Wildiers H, et al. Among authors: van oosterom at. Clin Pharmacokinet. 2003;42(14):1213-42. doi: 10.2165/00003088-200342140-00003. Clin Pharmacokinet. 2003. PMID: 14606930 Review.
472 results